A detailed history of Peregrine Capital Management LLC transactions in Vericel Corp stock. As of the latest transaction made, Peregrine Capital Management LLC holds 205,928 shares of VCEL stock, worth $8.21 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
205,928
Previous 211,353 2.57%
Holding current value
$8.21 Million
Previous $8.99 Million 27.94%
% of portfolio
0.21%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

SELL
$29.84 - $41.74 $161,882 - $226,439
-5,425 Reduced 2.57%
205,928 $6.48 Million
Q2 2025

Aug 01, 2025

BUY
$37.92 - $45.7 $8.01 Million - $9.66 Million
211,353 New
211,353 $8.99 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.88B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.